Work Here?
Cell Signaling Technology
Work Here?
Antibody development and validated research tools
Cell Signaling Technology
Work Here?
Antibody development and validated research tools
Overview
Cell Signaling Technology (CST) provides antibodies and related research products for scientists, especially in cancer research. Its main offering is antibodies that are thoroughly validated for multiple experimental applications, ensuring reliability across experiments. CST’s antibodies are produced by Ph.D.-level scientists who also deliver technical guidance and support to researchers to help achieve dependable results. The company differentiates itself through its strong emphasis on validation, quality control, and hands-on scientific support from its own researchers, operating with a family-owned, research-institute mindset rather than purely as a generic supplier. CST’s goal is to help researchers obtain accurate, reproducible data by supplying validated antibodies and expert methods guidance for use in the lab.
About Cell Signaling Technology
Industries
Biotechnology
Healthcare
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Danvers, Massachusetts
Founded
1999
Get referred to Cell Signaling Technology
See people who can refer or advise you
Simplify's Take
What believers are saying
- Quantum-Si and CST partnered June 2026 to validate PTM analysis on Proteus.
- CST and MJFF are developing Parkinson's antibodies, expanding disease-targeted reagent demand.
- Nordic Biosite began exclusive Nordic distribution for CST G4S Linker antibodies in August 2026.
What critics are saying
- CST sells research-use-only reagents; a single validation miss destroys trust fast.
- Spatial-biology rivals compress CST's mid-plex advantage as panels standardize.
- If citation leadership fades, CST's antibody brand moat collapses and pricing power erodes.
What makes Cell Signaling Technology unique
- CST remains scientist-owned and runs a 600-plus employee antibody platform from Danvers.
- CiteAb named CST 2026 Phospho Antibody Supplier of the Year.
- CST pairs validated antibodies with SignalStar multiplex IHC and PTM analysis partnerships.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Company Match
Tuition Reimbursement
Unlimited Paid Time Off
Parental Leave
Employee Assistance Program
Professional Development Budget
Growth & Insights and Company News
6 month growth
↑ 27%1 year growth
↑ 27%2 year growth
↑ 27%Nordic Biosite is the exclusive Nordic distributor for CST's G4S Linker Rabbit Monoclonal antibodies. news August 19 2026 Nordic Biosite is excited to announce its exclusive distribution partnership across Sweden, Denmark, Norway, and Finland for Cell Signaling Technology's (CST) premier line of Pre-GMP-grade G4S Linker antibodies. Chimeric Antigen Receptor (CAR) cell therapy is moving at a rapid pace, but researchers often struggle with reliable tracking reagents during early-phase development. This exclusive partnership changes that by bringing CST's premier translational tools directly to the Nordic region. Nordic Biosite is fully authorized to distribute the following early-access, Pre-GMP-grade products: * G4S Linker (E7O2V) Rabbit Monoclonal Antibody (PE Conjugate) * G4S Linker (E7O2V) Rabbit Monoclonal Antibody (Biotin Conjugate) By keeping these high-demand reagents in local stock, Nordic Biosite eliminates long international shipping delays, ensuring your lab has immediate access to the exact tools you need to advance your cell therapy research. News & articles. News August 13 2026 News July 31 2026 News June 30 2026 News August 19 2026 News August 18 2026 News August 13 2026 News July 31 2026 News June 30 2026 News August 19 2026 News August 18 2026
Leveragen partners with Cell Signaling Technology to advance reagent antibody innovation with proprietary nanobody Technology.
Cell Signaling Technology, Inc. is thrilled to announce the winners of the 5th annual Rising Black Scientists Awards!
Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, announced their partnership with The Michael J. Fox Foundation for Parkinson's Research (MJFF) today to identify and develop high-quality monoclonal antibodies for promising Parkinson's disease (PD) targets.
According to a recent announcement, Cell Signaling Technology (CST), a prominent life sciences discovery technology company, has partnered with Beyond Benign, a global green chemistry education nonprofit.
Cell Signaling Technology is Hiring for 8 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Cell Signaling Technology
Industries
Biotechnology
Healthcare
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Danvers, Massachusetts
Founded
1999
Cell Signaling Technology is Hiring for 8 Jobs on Simplify!
Find jobs on Simplify and start your career today